— Know what they know.
Not Investment Advice
Also trades as: IZO.CN (CNQ) · $vol 0M

IZOZF OTC

Izotropic Corporation
1W: -8.2% 1M: -20.2% 3M: -33.8% YTD: -41.3% 1Y: -54.1% 3Y: -19.6% 5Y: -78.7%
$0.13
-0.00 (-1.92%)
 
Weekly Expected Move ±21.7%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 35 · $8.8M mcap · 63M float · 0.031% daily turnover · Short 41% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$33K +5.9% ▲
Operating Income
-$1M +31.3% ▲
Net Income
-$2M +30.4% ▲
EPS (Diluted)
$-0.03 +38.9% ▲
EBITDA
-$1M +34.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$7K$31K$59K$0$33K
Gross Profit-$7K-$31K-$59K$0-$33K
Gross Margin—————
R&D Expenses$3M$2M$795K$681K$723K
SG&A Expenses$3M$3M$771K$1M$688K
Operating Expenses$6M$5M$2M$2M$1M
Operating Income-$6M-$5M-$2M-$2M-$1M
Operating Margin—————
Interest Expense$20K$294K$253K$286K$482K
Income Before Tax-$7M-$6M-$2M-$3M-$2M
Tax Expense$0$0$0$0$0
Net Income-$7M-$6M-$2M-$3M-$2M
Net Margin—————
EPS (Diluted)$-0.15$-0.11$-0.03$-0.05$-0.03
EBITDA-$6M-$5M-$2M-$2M-$1M
Shares Outstanding43M50M54M59M67M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms